Aspirin

fibrinogen beta chain ; Homo sapiens







47 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33307284 Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid. 2021 Feb 3
2 31356179 Evaluation of platelet reactivity during combined antiplatelet therapy in patients with stable coronary artery disease in relation to diabetes type 2 and the GPIIB/IIIA receptor gene polymorphism. 2019 Apr 1
3 25759104 Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy. 2015 May 1 1
4 24203353 Impact of -455G/a polymorphism of the β-fibrinogen gene on platelet aggregation in patients with acute coronary syndrome. 2014 Apr 1
5 24898335 Gender differences in hemorheological parameters and in in vitro platelet aggregation in acetylsalicylic acid and clopidogrel treated vascular patients. 2014 2
6 22994591 Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock. 2013 1
7 22395372 [The frequency of aspirin resistance by a modified thrombelastography method and its relationship with clinical and laboratory parameters in patients with stable coronary artery disease]. 2012 Jan 3
8 22507986 Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study. 2012 May 4 2
9 20624109 High-dose fibrinogen concentrate for haemostatic therapy of a major trauma patient with recent clopidogrel and aspirin intake. 2010 Oct 1
10 19129740 Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis. 2009 Jan 2
11 18239256 Hemorheological background of acetylsalicylic acid resistance. 2008 2
12 19100419 Incidence of aspirin resistance and its relationship with cardiovascular risk factors and graft function in renal transplant recipients. 2008 Dec 1
13 19126992 Relation of platelet aggregation and fibrinogen levels to advancing age in aspirin- and thienopyridine-treated patients. 2008 2
14 16756193 Flowcytometric evidence of platelet activation in patients on aspirin following myocardial infarction. 2006 Mar-Apr 1
15 16930084 Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables. 2006 1
16 16181986 Marked increase of fibrin gel permeability with very low dose ASA treatment. 2005 1
17 15049721 Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus. 2004 2
18 14593356 [Non ST elevation acute coronary syndrome. Some characteristics of coagulation and von Willebrand factor during short term use of ticlopidine or clopidogrel]. 2003 1
19 11145946 Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. 2001 Jan 1
20 11246553 Time and dose dependent augmentation of inhibitory effects of abciximab by aspirin. 2001 Feb 1
21 11460511 Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system. 2001 2
22 11672762 Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction. 2001 Nov 1 2
23 11723016 Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. 2001 Nov 27 1
24 11728532 Paradoxical activation of major platelet receptors in the methadone-maintained patients after single pill of aspirin. 2001 Nov 15 1
25 10193737 A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. 1999 Apr 1
26 11721406 [Characteristics of human platelet fibrinogen receptors regulated by anti-CD9 monoclonal antibodies]. 1999 Sep 1
27 10608044 Prothrombotic Consequences of the Oxidation of Fibrinogen and their Inhibition by Aspirin. 1998 5
28 8880021 Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient? 1996 Sep 2
29 8883279 Haemostatic parameters and lifestyle factors in elderly men in Italy and The Netherlands. 1996 Sep 1
30 7585737 Relationship of cigarette smoking to the severity of coronary and thoracic aortic atherosclerosis. 1995 1
31 21043735 Platelet Activation at High and Low Shear is Followed by Inactivation: The Clinical Relevance. 1995 2
32 7533066 Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets. 1994 Nov 1
33 8091447 Effect of plasma fibrinogen concentration on the inhibition of platelet aggregation after ticlopidine compared with aspirin. 1994 Oct 1
34 8121125 [Unstable angina: tissue-type plasminogen activator inhibitor and other hemostatic factors in aspirin and intravenous heparin administration]. 1993 1
35 1899346 Time-dependent association between platelet-bound fibrinogen and the Triton X-100 insoluble cytoskeleton. 1991 Feb 1 1
36 2024888 Adhesive interactions of platelets and their blockade. 1991 1
37 2746495 Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. 1989 Jul 1
38 2455569 Exposure of platelet fibrinogen receptors by a monoclonal antibody to CD9 antigen. 1988 Jul 2
39 3667609 Pertussis toxin can activate human platelets. Comparative effects of holotoxin and its ADP-ribosylating S1 subunit. 1987 Nov 5 1
40 3010580 The binding of fibrinogen to platelets in diabetes mellitus. 1986 Apr 4 1
41 3943666 Platelet fibrinogen binding in diabetes mellitus. Differences between binding to platelets from nonretinopathic and retinopathic diabetic patients. 1986 Feb 2
42 2981130 Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. 1985 Jan 1
43 6326566 Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin. 1984 May 2
44 6288146 Evidence for interaction between platelet fibrinogen receptors. 1982 Oct 1
45 7404479 Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B. 1980 Feb 29 2
46 139704 [Change in fibrinogen and enzymatic and nonenzymatic fibrinolytic activity of blood in patients with low-degree rheumatic heart disease under the effect of treatment with acetylsalicylic acid]. 1976 1
47 1215973 [Proceedings: Familial hemolytic-uremic syndrome. Studies on pathogenesis in the survivors]. 1975 Dec 20 2